Rowley Pharmaceutical Company Produces a Drug That Promotes New Blood

Rowley Pharmaceutical company produces a drug that promotes new blood vessel growth. Is there any application for this drug in wound treatment?

A) It could be very beneficial. One of the biggest problems with wound infections is that they are anaerobic, because the blood supply to the area is usually compromised. Certain pathogenic microbes then thrive in this environment, creating very serious wound infections.
B) It would not be beneficial. Part of the reason abscesses lack blood flow is to keep bacteria from spreading to other areas of the body. Increasing blood flow to the area will provide a way for these bacteria to infect other organ systems.
C) It could be dangerous. Wounds need to cut off blood supply to prevent the patient from bleeding to death. Increasing blood vessel development in the wound site might cause the patient to bleed out.
D) There would be no beneficial effect. The immune response is already in place in the wound site, so increasing blood cell delivery to the area wouldn't increase or decrease the rate of wound healing.
E) It would be dangerous. New blood vessels would reduce the anaerobic nature of the wound but it would also always result in massive edema which may lead to permanent loss of function.